SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3ASR - Automatic shelf registration statement of securities of well-known seasoned issuers:
SEC Accession No. 0001714899-24-000096
Filing Date
2024-03-22
Accepted
2024-03-22 16:01:55
Documents
7
Effectiveness Date
2024-03-22

Document Format Files

Seq Description Document Type Size
1 S-3ASR s-3pipe32224.htm S-3ASR 254846
2 EX-FILING FEES exhibit1071filingfees-3pipe.htm EX-FILING FEES 16138
3 EX-5.1 exhibit51-sx3pipe.htm EX-5.1 16928
4 EX-23.1 exhibit231-sx3pipe.htm EX-23.1 3820
5 denali_txlogox02.jpg GRAPHIC 604226
6 wilsonsonsiniloga2aa.jpg GRAPHIC 363953
7 wilsonsonsinilogo1aa.jpg GRAPHIC 362252
  Complete submission text file 0001714899-24-000096.txt   2098343
Mailing Address 161 OYSTER POINT BLVD. SOUTH SAN FRANCISCO CA 94080
Business Address 161 OYSTER POINT BLVD. SOUTH SAN FRANCISCO CA 94080 (650) 866-8548
Denali Therapeutics Inc. (Filer) CIK: 0001714899 (see all company filings)

IRS No.: 463872213 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3ASR | Act: 33 | File No.: 333-278174 | Film No.: 24775124
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)